clemastine fumarate 1.34 MG
RxNorm concept 857400, clinical drug component (scdc).
- RxCUI
- 857400
- Term type
- Clinical drug component (SCDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/857400 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- clemastine fumarate 1.34 MG Oral Tablet (SCD, constitutes)
- 12 HR clemastine fumarate 1.34 MG Extended Release Oral Tablet (SCD, constitutes)
- clemastine fumarate 1.34 MG Oral Tablet [Tavist] (SBD, constitutes)
- clemastine fumarate 1.34 MG Oral Tablet [Dayhist-1] (SBD, constitutes)
- 12 HR clemastine fumarate 1.34 MG Extended Release Oral Tablet [Wal-Hist 12 HR Relief] (SBD, constitutes)
- clemastine (IN, has ingredient)
- clemastine fumarate (PIN, has precise ingredient)
- clemastine fumarate 1.34 MG [Tavist] (SBDC, has tradename)
- clemastine fumarate 1.34 MG [Dayhist-1] (SBDC, has tradename)
- clemastine fumarate 1.34 MG [Wal-Hist 12 HR Relief] (SBDC, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 857400 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/857400 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 857400. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.